CODX Co-Diagnostics, Inc.

Nasdaq codiagnostics.com


$ 0.32 $ -0.02 (-5.11 %)    

Thursday, 20-Nov-2025 14:43:46 EST
QQQ $ 589.80 $ -21.87 (-3.58 %)
DIA $ 459.68 $ -7.00 (-1.5 %)
SPY $ 656.04 $ -16.83 (-2.5 %)
TLT $ 89.21 $ 0.22 (0.25 %)
GLD $ 375.35 $ 0.17 (0.05 %)
$ 0.3423
$ 0.35
$ 0.32 x 6
$ 0.33 x 100
$ 0.32 - $ 0.36
$ 0.23 - $ 1.55
1,075,348
na
20.84M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-16-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-24-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-10-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-28-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-25-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 co-diagnostics-q3-eps-016-beats-017-estimate-sales-145380k-miss-150000k-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17...

 co-diagnostics-engages-maxim-group-to-explore-strategic-options-for-indian-joint-venture-cosara-including-potential-spac-merger

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented ...

 co-diagnostics-forms-new-artificial-intelligence-business-unit-to-integrate-its-current-planned-ai-applications-into-co-dx-primer-ai

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, ...

 co-diagnostics--files-for-offering-12m-shares-of-common-stock-and-725000-pre-funded-warrants

-SEC Filing

 why-is-co-diagnostics-stock-sinking-tuesday

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...

 co-diagnostics-announces-7m-registered-direct-offering-of-12727272-shares-at-a-price-of-055share

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, p...

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-3-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

 co-diagnostics-stock-is-rocketing-higher-monday-whats-going-on

Co-Diagnostics shares are trading higher Monday after the company signed a definitive agreement to establish CoMira Diagnostics.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION